1-20 of 25
Rajiv Bassi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract #5659: Anti-TGF beta receptor II antibody abrogates FoxP3+/TGF \#946; RII + Treg cells and enhances antitumor immunity against tumor growth and metastasis

Kyla Carroll, Zhaojing Zhong, Desiree Policarpio, Michael Gregory, Rajiv Bassi, Xenia Jimenez, Kris Persaud, Paul Balderes, Dale Ludwig, Larry Witte, Zhenping Zhu, Yan Wu
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5659.
Published: 01 May 2009
View article titled, Abstract #5659: Anti-TGF beta receptor II antibody abrogates FoxP3+/TGF \#946; RII + Treg cells and enhances antitumor immunity against tumor growth and metastasis
Journal Articles

Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells

Zhaojing Zhong, Desiree Policarpio, Kyla Carroll, Michael Gregory, Rajiv Bassi, Marie Prewette, Su Wang, Jim Tonra, Xenia Jimenez, Jackie Doody, Kris Persaud, Paul Balderes, Dale Ludwig, Larry Witte, Zhenping Zhu, Yan Wu
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 844.
Published: 01 May 2009
View article titled, Abstract #844: Anti-TGF beta receptor II antibody suppresses tumor growth and metastasis through inhibiting TGF beta autocrine stimulation of tumor cells and myeloid cells
Journal Articles

Abstract #2923: Preclinical pharmacokinetic and pharmacodynamic evaluation of the anti-FLT3 monoclonal antibody IMC-EB10

Erik Corcoran, Rajiv Bassi, Yiwen Li, David Surguladze, James Tonra
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2923.
Published: 01 May 2009
View article titled, Abstract #2923: Preclinical pharmacokinetic and pharmacodynamic evaluation of the anti-FLT3 monoclonal antibody IMC-EB10
Journal Articles

Abstract #2774: The fully human EGFR antibody IMC-11F8 significantly increases the antitumor effects of cisplatin+gemcitabine in human non-small cell lung cancer models

Marie Prewett, Rajiv Bassi, Hagop Youssoufian, Eric Rowinsky, James Tonra
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2774.
Published: 01 May 2009
View article titled, Abstract #2774: The fully human EGFR antibody IMC-11F8 significantly increases the antitumor effects of cisplatin+gemcitabine in human non-small cell lung cancer models
Journal Articles

Abstract #4089: Mechanism of potentiation of the antitumor cytotoxic therapy by treatment with an antagonist antibody to VEGFR-3 in subcutaneous tumor xenograft models

Marguerita O’Mahony, Hui Xiao, Marie Prewett, Rajiv Bassi, Chris Damoci, James Tonra, Bronislaw Pytowski
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4089.
Published: 01 May 2009
View article titled, Abstract #4089: Mechanism of potentiation of the antitumor cytotoxic therapy by treatment with an antagonist antibody to VEGFR-3 in subcutaneous tumor xenograft models
Journal Articles

Cetuximab significantly increases the anti-tumor effects of irinotecan + oxaliplatin (IROX) in human colorectal cancer xenograft models.

Marie Prewett, Rajiv Bassi, James Tonra
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1322.
Published: 01 May 2008
View article titled, Cetuximab significantly increases the anti-tumor effects of irinotecan + oxaliplatin (IROX) in human colorectal cancer xenograft models.
Journal Articles

Inhibition of leukemia growth by a recombinant gelonin conjugate of anti-FLT3 monoclonal antibody

Yiwen Li, Michael Rosenblum, Hongli Li, Rajiv Bassi, Wenzhi Tian, John W. Marks, Daniel Hicklin
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4114.
Published: 01 May 2007
View article titled, Inhibition of leukemia growth by a recombinant gelonin conjugate of anti-FLT3 monoclonal antibody
Journal Articles

Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo

Roberto DiRenzo, Maria Malabunga, Marie Prewett, Rajiv Bassi, David Surguladze, Juqun Shen, James Tonra, Paul Kussie, Haijun Sun
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2080.
Published: 01 May 2007
View article titled, Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models <em>in vivo</em>
Journal Articles

IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts.

Marie Prewett, Christopher Damoci, Rajiv Bassi, Dale Ludwig, Daniel Hicklin, James Tonra
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 652.
Published: 01 May 2007
View article titled, IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts.
Journal Articles

Mechanism for the benefits of cetuximab in combination with oxaliplatin, in oxaliplatin sensitive and resistant colon cancer cell lines

Dhanvanthri Deevi, Rajiv Bassi, Maxine Melchior, Lee Ellis, Fan Fan, Daniel Hicklin, James Tonra, Marie Prewett
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2329.
Published: 01 May 2007
View article titled, Mechanism for the benefits of cetuximab in combination with oxaliplatin, in oxaliplatin sensitive and resistant colon cancer cell lines
Journal Articles

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Jennifer M. O'Toole, Karen E. Rabenau, Kerri Burns, Dan Lu, Venkat Mangalampalli, Paul Balderes, Nicole Covino, Rajiv Bassi, Marie Prewett, Kimberly J. Gottfredsen, Megan N. Thobe, Yuan Cheng, Yiwen Li, Daniel J. Hicklin, Zhenping Zhu, Susan E. Waltz, Michael J. Hayman, Dale L. Ludwig, Daniel S. Pereira
Journal: Cancer Research
Cancer Res (2006) 66 (18): 9162–9170.
https://doi.org/10.1158/0008-5472.CAN-06-0283
Published: 18 September 2006
View article titled, Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
Open the PDF for Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member in another window
Includes: Supplementary data
Journal Articles

Antibody mediated VEGFR-3 inhibition potentiates the anti-tumor effects of cytotoxic therapy in subcutaneous xenograft models

James R. Tonra, Marie Prewett, Rajiv Bassi, Chris Damoci, Kris Persaud, Daniel J. Hicklin, Bronislaw Pytowski
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 875–876.
Published: 15 April 2006
View article titled, Antibody mediated VEGFR-3 inhibition potentiates the anti-tumor effects of cytotoxic therapy in subcutaneous xenograft models
Journal Articles

Inhibitory activity of the anti-EGFR antibody cetuximab on EFGR mutants harboring mutations in the kinase domain

Jacqueline F. Doody, Ying Wang, Sheetal Patel, Robin Rolser, Hui-Hsien Chiang, Jason Gerlak, Diane Macari, Chris Joynes, Rajiv Bassi, Philipp Steiner, Daniel J. Hicklin, Yaron R. Hadari
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 293.
Published: 15 April 2006
View article titled, Inhibitory activity of the anti-EGFR antibody cetuximab on EFGR mutants harboring mutations in the kinase domain
Journal Articles

Enhanced anti-tumor activity with cetuximab (ERBITUX®) in combination with oxaliplatin in human colon carcinoma xenografts

Marie Prewett, James R. Tonra, Rajiv Bassi, Francine Carrick, Genevieve Makhoul, Bridget Finnerty, Larry Witte, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1192.
Published: 01 May 2005
View article titled, Enhanced anti-tumor activity with cetuximab (ERBITUX®) in combination with oxaliplatin in human colon carcinoma xenografts
Journal Articles

Suppression of leukemia growth in vivo by a novel anti-FLT3 antibody-auristatin conjugate

Yiwen Li, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Venkat Mangalampalli, Dale L. Ludwig, Paul Balderes, Larry Witte, Zhenping Zhu, Damon Meyer, Angelyn Larkin, Peter Senter, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1455.
Published: 01 May 2005
View article titled, Suppression of leukemia growth in vivo by a novel anti-FLT3 antibody-auristatin conjugate
Journal Articles

Characterization of novel human monoclonal antibodies against melanoma associated antigen gp75/TRP-1

Dipa Patel, Armin Lahiji, Maxine Melchior, Stanley Ng, Rajiv Bassi, Yan Wu, Peter Bohlen, Daniel Hicklin, Xiaoqiang Kang
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 165.
Published: 01 May 2005
View article titled, Characterization of novel human monoclonal antibodies against melanoma associated antigen gp75/TRP-1
Journal Articles

Therapeutic implications of an antibody to the human macrophage-stimulating protein receptor tyrosine kinase (RON)

Daniel S. Pereira, Jennifer M. O’Toole, Karen E. Rabenau, Dan Lu, Venkat Mangalampalli, Henry Koo, Anthony Kayas, Julie P. Yuen, Paul Balderes, Nicole Covino, Rajiv Bassi, Andrea Hooper, Philipp Steiner, Xenia Jimenez, Zhenping Zhu, Dale L. Ludwig, Daniel J. Hicklin, Larry Witte
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 130–131.
Published: 01 May 2005
View article titled, Therapeutic implications of an antibody to the human macrophage-stimulating protein receptor tyrosine kinase (RON)
Journal Articles

Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice

Obdulio Piloto, Mark Levis, David Huso, Yiwen Li, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Paul Balderes, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Daniel J. Hicklin, Donald Small
Journal: Cancer Research
Cancer Res (2005) 65 (4): 1514–1522.
https://doi.org/10.1158/0008-5472.CAN-04-3081
Published: 25 February 2005
View article titled, Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Open the PDF for Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice in another window
Journal Articles

Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Dale L. Ludwig, James R. Tonra, Douglas Burtrum, Marie Prewett, Rajiv Bassi, Andrea Hooper, Daniel S. Pereira, Bridget Finnerty, Eric Corcoran, Larry Witte, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 509.
Published: 01 April 2004
View article titled, Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.
Journal Articles

DEGA/AMIGO-2, a leucine-rich repeat family member differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability and tumorigenicity

Daniel S. Pereira, Karen E. Rabenau, Jennifer M. O’Toole, Rajiv Bassi, Helen Kotanides, Dale L. Ludwig, Larry Witte
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1168.
Published: 01 April 2004
View article titled, DEGA/AMIGO-2, a leucine-rich repeat family member differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability and tumorigenicity